References
- SethAOhDBLimYTNanomaterials for enhanced immunity as an innovative paradigm in nanomedicineNanomedicine (Lond)201510695997525867860
- SchinnerlingKSotoLGarcia-GonzalezPCatalanDAguillonJCSkewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritisAutoimmun Rev201514651752725633325
- NevesARLucioMLimaJLReisSResveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactionsCurr Med Chem201219111663168122257059
- AhnJLeeHKimSHaTResveratrol inhibits TNF-alpha-induced changes of adipokines in 3T3-L1 adipocytesBiochem Biophys Res Commun2007364497297717967414
- BertelliAABaccaliniRBattagliaEFalchiMFerreroMEResveratrol inhibits TNF alpha-induced endothelial cell activationTherapie200156561361611806302
- BiXLYangJYDongYXResveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microgliaInt Immunopharmacol20055118519315589480
- ButtariBProfumoESegoniLResveratrol counteracts inflammation in human M1 and M2 macrophages upon challenge with 7-oxo-cholesterol: potential therapeutic implications in atherosclerosisOxid Med Cell Longev2014201425754324895526
- CsakiCKeshishzadehNFischerKShakibaeiMRegulation of inflammation signalling by resveratrol in human chondrocytes in vitroBiochem Pharmacol200875367768717959154
- ElmaliNEsenkayaIHarmaAErtemKTurkozYMizrakBEffect of resveratrol in experimental osteoarthritis in rabbitsInflamm Res200554415816215883738
- KimGYChoHAhnSCOhYHLeeCMParkYMResveratrol inhibits phenotypic and functional maturation of murine bone marrow-derived dendritic cellsInt Immunopharmacol20044224525314996416
- SvajgerUObermajerNJerasMDendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activationImmunology2010129452553520002210
- SilvaAMOliveiraMISetteLResveratrol as a natural anti-tumor necrosis factor-alpha molecule: implications to dendritic cells and their crosstalk with mesenchymal stromal cellsPLoS One201493e9140624614867
- CsiszarASmithKLabinskyyNOroszZRiveraAUngvariZResveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibitionAm J Physiol Heart Circ Physiol20062914H1694H169916973825
- KangOHJangHJChaeHSAnti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPKPharmacol Res200959533033719416633
- MannaSKMukhopadhyayAAggarwalBBResveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidationJ Immunol2000164126509651910843709
- WangXZhangCHuangGResveratrol inhibits dysfunction of dendritic cells from chronic obstructive pulmonary disease patients through promoting miR-34Int J Clin Exp Pathol2015855145515226191210
- SummerlinNSooEThakurSQuZJambhrunkarSPopatAResveratrol nanoformulations: challenges and opportunitiesInt J Pharm2015479228229025572692
- LimSBBanerjeeAOnyukselHImprovement of drug safety by the use of lipid-based nanocarriersJ Control Release20121631344522698939
- MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
- NevesARLucioMMartinsSLimaJLReisSNovel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailabilityInt J Nanomedicine2013817718723326193
- GokceEHKorkmazEDelleraESandriGBonferoniMCOzerOResveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applicationsInt J Nanomedicine201271841185022605933
- SelvamuthukumarSVelmuruganRNanostructured lipid carriers: a potential drug carrier for cancer chemotherapyLipids Health Dis20121115923167765
- BashaGNovobrantsevaTIRosinNInfluence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cellsMol Ther201119122186220021971424
- ErniCSuardCFreitasSDreherDMerkleHPWalterEEvaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cellsBiomaterials200223234667467612322988
- OliveiraMISantosSGOliveiraMJTorresALBarbosaMAChitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulationEur Cell Mater201224136152 discussion 152–15322828991
- SallustoFLanzavecchiaAEfficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alphaJ Exp Med19941794110911188145033
- ChapuisFRosenzwajgMYagelloMEkmanMBiberfeldPGluckmanJCDifferentiation of human dendritic cells from monocytes in vitroEur J Immunol19972724314419045914
- PahlHLActivators and target genes of Rel/NF-kappaB transcription factorsOncogene199918496853686610602461
- GargADRomanoERufoNAgostinisPImmunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translationCell Death Differ201623693895126891691
- ChenKWangJMYuanRTissue-resident dendritic cells and diseases involving dendritic cell malfunctionInt Immunopharmacol20163411526906720
- KatakowskiJAMukherjeeGWilnerSEDelivery of siRNAs to dendritic cells using DEC205-targeted lipid nanoparticles to inhibit immune responsesMol Ther201624114615526412590
- WarashinaSNakamuraTSatoYA lipid nanoparticle for the efficient delivery of siRNA to dendritic cellsJ Control Release201622518319126820519
- BhargavaAMishraDKhanSVarshneySKBanerjeeSMishraPKAssessment of tumor antigen-loaded solid lipid nanoparticles as an efficient delivery system for dendritic cell engineeringNanomedicine (Lond)2013871067108423311961
- GettsDRSheaLDMillerSDKingNJHarnessing nanoparticles for immune modulationTrends Immunol201536741942726088391
- MullerRHSchwarzCMehnertWLucksJSProduction of solid lipid nanoparticles (SLN) for controlled drug deliveryProc Int Symp Control Release Bioact Mater199320480481
- JenningVGohlaSMullerRHSolid lipid nanoparticles (SLN): effect of homogenization parameters on drug stabilityProceedings 2nd World Meeting APGI/APVParis1998619620
- PhanseYRamer-TaitAEFriendSLAnalyzing cellular internalization of nanoparticles and bacteria by multi-spectral imaging flow cytometryJ Vis Exp201264e388422710268
- ButtariBProfumoEFacchianoFResveratrol prevents dendritic cell maturation in response to advanced glycation end productsOxid Med Cell Longev2013201357402923936610
- ElmaliNBaysalOHarmaAEsenkayaIMizrakBEffects of resveratrol in inflammatory arthritisInflammation2007301–21617115116